top of page
Protekt Therapeutics
Focuses on developing PKR inhibitors to treat neurodegenerative diseases like Alzheimer’s, targeting key processes involved in cognitive decline and memory impairment.
Company Name | Neurotech Category | Market Category | Company Founded Year | Company Location |
|---|---|---|---|---|
Protekt Therapeutics | NeuroPharmacology | NeuroBioTechnology | Biotechnology & Biopharmaceutical | 2014 | Ness Ziona |
Focuses on developing PKR inhibitors to treat neurodegenerative diseases like Alzheimer’s, targeting key processes involved in cognitive decline and memory impairment.
bottom of page